AU2001277959A1 - Human kinases - Google Patents

Human kinases

Info

Publication number
AU2001277959A1
AU2001277959A1 AU2001277959A AU7795901A AU2001277959A1 AU 2001277959 A1 AU2001277959 A1 AU 2001277959A1 AU 2001277959 A AU2001277959 A AU 2001277959A AU 7795901 A AU7795901 A AU 7795901A AU 2001277959 A1 AU2001277959 A1 AU 2001277959A1
Authority
AU
Australia
Prior art keywords
human kinases
kinases
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277959A
Inventor
Chandra S. Arvizu
Olga Bandman
Mariah R. Baughn
Neil Burford
Narinder K. Chawla
Li Ding
Aina M. Dyung
Vicki S. Elliott
Ameena R. Gandhi
Kimberly J. Gietzen
Sara R. Greenwald
Rajagopal Gururajan
April J. A. Hafalia
Jennifer L. Jackson
Liam Kearney
Farrah A. Khan
Preeti Lal
Yan Lu
Danniel B. Nguyen
Jennifer L. Policky
Jayalaxmi Ramkumar
Shirley A. Recipon
Y. Tom Tang
Michael Thornton
Catherine M. Tribouley
Roderick T. Walsh
Yuming Xu
Junming Yang
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001277959A1 publication Critical patent/AU2001277959A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2001277959A 2000-07-21 2001-07-20 Human kinases Abandoned AU2001277959A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US22003800P 2000-07-21 2000-07-21
US60/220,038 2000-07-21
US22211200P 2000-07-28 2000-07-28
US60/222,112 2000-07-28
US22283100P 2000-08-04 2000-08-04
US60/222,831 2000-08-04
US22472900P 2000-08-11 2000-08-11
US60/224,729 2000-08-11
PCT/US2001/023092 WO2002008399A2 (en) 2000-07-21 2001-07-20 Human kinases

Publications (1)

Publication Number Publication Date
AU2001277959A1 true AU2001277959A1 (en) 2002-02-05

Family

ID=27499171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277959A Abandoned AU2001277959A1 (en) 2000-07-21 2001-07-20 Human kinases

Country Status (5)

Country Link
EP (1) EP1356032A2 (en)
JP (1) JP2004527209A (en)
AU (1) AU2001277959A1 (en)
CA (1) CA2416414A1 (en)
WO (1) WO2002008399A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1484408A1 (en) * 1999-09-28 2004-12-08 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US20020090701A1 (en) * 2000-04-13 2002-07-11 Rosana Kapeller-Libermann 14257 novel protein kinase molecules and their uses therefor
US7094587B2 (en) 2000-06-27 2006-08-22 Millennium Pharmaceuticals, Inc. 16002 Molecules and uses therefor
CA2416800A1 (en) * 2000-07-28 2002-02-07 Chiron Corporation Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides
EP1364015A2 (en) * 2000-09-05 2003-11-26 Incyte Genomics, Inc. Molecules for diagnostics and therapeutics
WO2003023034A2 (en) * 2001-09-12 2003-03-20 Bayer Healthcare Ag Regulation of human tau-tubulin kinase
EP1478743A4 (en) * 2002-03-05 2005-06-29 Applera Corp Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003084992A1 (en) * 2002-04-05 2003-10-16 Riken Novel proteins and dnas encoding the same
JP2003289876A (en) * 2002-04-05 2003-10-14 Takeda Chem Ind Ltd Preventive and/or therapeutic agent for cancer
US20050208492A1 (en) * 2002-05-15 2005-09-22 Jiing-Ren Liou Regulation of human serine/threonine kinase
EP1575518A4 (en) 2002-10-10 2007-08-22 Wyeth Corp Compositions, organisms and methodologies employing a novel human kinase
EP1554385A2 (en) 2002-10-24 2005-07-20 Wyeth Calcineurin-like human phoshphoesterase
AU2003298689A1 (en) 2002-11-21 2004-06-18 Wyeth Methods for diagnosing rcc and other solid tumors
AU2003290664A1 (en) * 2002-11-27 2004-06-23 Wei Liu Compositions, organisms and methodologies employing a novel human kinase
WO2004085673A2 (en) * 2003-03-20 2004-10-07 Metabolex, Inc. Compositions and methods of using hexokinase v
WO2004087903A2 (en) * 2003-03-28 2004-10-14 Wyeth Novel proteins homologous to kinase suppressor of ras
US20050125852A1 (en) * 2003-05-09 2005-06-09 Sugen, Inc. Novel kinases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183962B1 (en) * 1998-09-09 2001-02-06 Millennium Pharmaceuticals, Inc. Protein kinase molecules and uses therefor

Also Published As

Publication number Publication date
WO2002008399A2 (en) 2002-01-31
JP2004527209A (en) 2004-09-09
WO2002008399A3 (en) 2003-08-28
EP1356032A2 (en) 2003-10-29
CA2416414A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU9517301A (en) Implant
AU2001241963A1 (en) Improved medical procedure
AU2002223827A1 (en) Well treatment
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2001260327A1 (en) Chair
AU2001263841A1 (en) Implant
AU2000267458A1 (en) Hypercomputer
AU2001254786A1 (en) Medical implant
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001259702A1 (en) Tissue regrafting
AU2001280598A1 (en) Anti-occlusion catheter
AU2001268525A1 (en) Human kinases
AU2001277959A1 (en) Human kinases
AU2001238488A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU2001233208A1 (en) Human sulfatases
AU2292301A (en) Human kinases
AU2002227925A1 (en) Human beta-defensin-3
AU2001270129A1 (en) Human phosphodiesterases
AU2001255573A1 (en) Human kinases
AU2002227352A1 (en) Human kinases
AU2001275723A1 (en) Bougie
AU2001247841A1 (en) Medical procedure
AU2001252200A1 (en) Chair